Published in Z Gastroenterol on February 01, 2005
MIPS: analysis and annotation of proteins from whole genomes. Nucleic Acids Res (2004) 8.58
Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology (2001) 3.38
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 3.03
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Congenital heart disease among 160 480 liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment. Br Heart J (1981) 2.80
Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis. Lancet (1996) 2.65
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Drug interactions with cimetidine. Clin Pharmacokinet (1982) 2.49
Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37
The conducting tissues in congenitally corrected transposition. Circulation (1974) 2.27
Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood (1994) 2.16
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy (2010) 2.11
Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest (1996) 2.10
Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10
Physicians' attitudes toward using deception to resolve difficult ethical problems. JAMA (1989) 2.09
Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion (1995) 2.05
[Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons]. Z Gastroenterol (1996) 2.04
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest (1992) 2.00
Transcatheter occlusion of the patent ductus arteriosus with Cook detachable coils. Heart (1996) 1.91
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol (1981) 1.86
The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol (2000) 1.77
Risk of mortality, cancer incidence, and stroke in a population potentially exposed to cadmium. Occup Environ Med (2000) 1.77
ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr (2002) 1.75
Drug-associated pancreatitis: facts and fiction. Pancreas (1996) 1.75
Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am (2000) 1.69
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. J Clin Invest (1998) 1.68
Cardiac angiosarcoma: case report and review of the literature. Z Kardiol (2005) 1.65
Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol (1974) 1.63
Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc (2007) 1.60
Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med (1992) 1.59
Morphogenesis of bulboventricular malformations. I. Consideration of embryogenesis in the normal heart. Br Heart J (1974) 1.57
Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis (2012) 1.56
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology (1997) 1.56
Gastrin and G-cells in the antral mucosa of patients with pernicious anaemia, acromegaly and hyperparathyroidism and in a Zollinger-Ellison tumour of the pancreas. Eur J Clin Invest (1971) 1.52
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol (1994) 1.51
Coarctation co-existing with tetralogy of Fallot and pulmonary atresia. Cardiol Young (2001) 1.47
Pharmacokinetics of pindolol in man. Eur J Clin Pharmacol (1974) 1.46
From fate to tragedy: the changing meanings of life, death, and AIDS. Ann Intern Med (1998) 1.46
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Morphogenesis of bulboventricular malformations. II. Observations on malformed hearts. Br Heart J (1974) 1.45
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant (2001) 1.44
[Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (1999) 1.43
The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc (2001) 1.43
Mucosal gastrin concentration, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer. Gut (1976) 1.42
Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet (1980) 1.42
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut (2009) 1.40
Is radical scavenging necessary in the treatment of inflammatory bowel disease? Gastroenterology (1991) 1.39
First description of three patients with multifocal lymphangiomatosis and protein-losing enteropathy following palliation of complex congenital heart disease with total cavo-pulmonary connection. Pediatr Cardiol (2008) 1.39
[The duodenojejunal flexure--a gap in the routine diagnosis of gastrointestinal bleeding]. Dtsch Med Wochenschr (1999) 1.38
A national facility for small area disease mapping and rapid initial assessment of apparent disease clusters around a point source: the UK Small Area Health Statistics Unit. J Public Health Med (1999) 1.38
Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology (1996) 1.37
Increasing organ donation in the African-American community: altruism in the face of an untrustworthy system. Ann Intern Med (1999) 1.37
Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing. Brain (2009) 1.37
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
Balloon dilatation of the arterial duct in congenital heart disease. Lancet (1992) 1.35
Cardiac specialized tissue in hearts with an apparently single ventricular chamber (double inlet left ventricle). Am J Cardiol (1974) 1.33
The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man. Clin Pharmacol Ther (1975) 1.33
Clinical pharmacokinetics of cimetidine. Clin Pharmacokinet (1984) 1.32
Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial. N Engl J Med (1979) 1.32
Outcome of treatment for neonates referred to a supraregional cardiac centre 1976-78. Arch Dis Child (1982) 1.31
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29
Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol (2001) 1.29
Cimetidine plasma concentration-response relationships. Clin Pharmacol Ther (1981) 1.29
Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology (1985) 1.29
Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study. Br Heart J (1988) 1.27
Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26
Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept (1994) 1.25
Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion (1995) 1.23
Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut (1982) 1.22
4D-MR flow analysis in patients after repair for tetralogy of Fallot. Eur Radiol (2011) 1.21
Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol (1975) 1.21
The conducting system in congenitally corrected transposition. Lancet (1973) 1.20
Lactoperoxidase binding to streptococci. Infect Immun (1979) 1.20
Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol (1975) 1.20
Captopril in treatment of infant heart failure: a preliminary report. Int J Cardiol (1987) 1.19
Balloon expandable stents for systemic venous pathway stenosis late after Mustard's operation. Heart (1998) 1.18
Critical aortic stenosis in early infancy. Anatomic and echocardiographic substrates of successful open valvotomy. J Thorac Cardiovasc Surg (1991) 1.18
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Human pancreatic exocrine response to nutrients in health and disease. Gut (2005) 1.16
D-bulboventricular loop with L-transposition in situs inversus. Circulation (1972) 1.16
Nissen vs Toupet laparoscopic fundoplication. Surg Endosc (2002) 1.15
Temporary tracheobronchial stenting in malignant lymphoma. Ann Thorac Surg (1999) 1.15
Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis. Digestion (2003) 1.14
Social class, health and aging: socioeconomic determinants of self-reported morbidity among the noninstitutionalized elderly in Canada. Can J Public Health (1996) 1.14
Aminoalkylindoles: actions on specific G-protein-linked receptors. J Pharmacol Exp Ther (1991) 1.14
Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther (1976) 1.14
Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology (1986) 1.14
Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol (1986) 1.14
Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther (2011) 1.14
Incidence and prognosis of obstruction of the left ventricular outflow tract in Liverpool (1960-91): a study of 313 patients. Br Heart J (1994) 1.12
Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans. Gut (2002) 1.12